Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
mRNA
Biotech
GSK's mRNA flu vaccine finally bests tricky B strains in phase 2
After an initial defeat against the biggest barrier to mRNA flu vaccines, GSK has returned with a reformulated candidate that has delivered the goods.
James Waldron
Sep 12, 2024 4:52am
Carisma, Moderna expand cell therapy collab to autoimmune area
Sep 10, 2024 12:31pm
Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B
Aug 16, 2024 8:25am
Sanofi will drop dwarfism drug as part of rare disease clear-out
Jul 25, 2024 7:58am
Langer steps down from Moderna board after 14 years
Jul 23, 2024 12:18pm
BARDA hands Moderna $176M to push bird flu shot through trials
Jul 2, 2024 8:42am